Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma

References

• Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Molecular targets for biological therapies of severe asthma. Front Immunol. 2020;11:603312. doi:10.3389/fimmu.2020.603312
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention (2021 update). Available from: https://ginasthma.org/gina-reports/ Accessed October 27, 2021.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Thomas M, Kay S, Pike J, et al. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J. 2009;18(1):41–49. doi:10.4104/pcrj.2009.00010
   PubMedGoogle Scholar
• Nakamura Y, Tamaoki J, Nagase H, et al. Japanese guidelines for adult asthma 2020. Allergol Int. 2020;69(4):519–548. doi:10.1016/j.alit.2020.08.001
   PubMed Web of Science ®Google Scholar
• Chan R, RuiWen Kuo C, Lipworth B. Pragmatic clinical perspective on biologics for severe refractory Type 2 asthma. J Allergy Clin Immunol Pract. 2020;8(10):3363–3370. doi:10.1016/j.jaip.2020.06.048
   PubMed Web of Science ®Google Scholar
• Bousquet J, Brusselle G, Buhl R, et al. Care pathways for the selection of a biologic in severe asthma. Eur Respir J. 2017;50:6. doi:10.1183/13993003.01782-2017
   Web of Science ®Google Scholar
• Kroes JA, Zielhuis SW, van Roon EN, Ten Brinke A. Prediction of response to biological treatment with monoclonal antibodies in severe asthma. Biochem Pharmacol. 2020;179:113978. doi:10.1016/j.bcp.2020.113978
   PubMed Web of Science ®Google Scholar
• Kavanagh JE, d’Ancona G, Elstad M, et al. Real-world effectiveness and the characteristics of a “super-responder” to mepolizumab in severe eosinophilic asthma. Chest. 2020;158(2):491–500. doi:10.1016/j.chest.2020.03.042
   PubMed Web of Science ®Google Scholar
• Eger K, Kroes JA, Ten Brinke A, Bel EH. Long-term therapy response to anti-il-5 biologics in severe asthma-a real-life evaluation. J Allergy Clin Immunol Pract. 2021;9(3):1194–1200. doi:10.1016/j.jaip.2020.10.010
   PubMed Web of Science ®Google Scholar
• Matsumoto-Sasaki M, Shimizu K, Suzuki M, Nakamaru Y, Konno S. [A case of severe asthma switched to mepolizumab due to late-occurring unresponsiveness to benralizumab]. Arerugi. 2020;69(8):678–682. Japanese. doi:10.15036/arerugi.69.678
   PubMedGoogle Scholar
• Matsumoto-Sasaki M, Shimizu K, Suzuki M, Nakamaru Y, Konno S. [A case of severe asthma who required a switch of four biologics: differential responses on upper and lower airways]. Arerugi. 2021;70(4):315–320. Japanese. doi:10.15036/arerugi.70.315
   Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST
   PubMed Web of Science ®Google Scholar
• Tojo N, Suga H, Kambe M. [Lung function testing –the Official Guideline of the Japanese Respiratory Society]. Rinsho Byori. 2005;53(1):77–81. Japanese.
   PubMedGoogle Scholar
• Tokunaga T, Sakashita M, Haruna T, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy. 2015;70(8):995–1003. doi:10.1111/all.12644
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Boyce JA. Aspirin-exacerbated respiratory disease–new prime suspects. N Engl J Med. 2016;374(5):484–488. doi:10.1056/NEJMcibr1514013
   PubMed Web of Science ®Google Scholar
• Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011;38(4):456–461. doi:10.1016/j.anl.2010.11.016
   PubMed Web of Science ®Google Scholar
• Tajiri T, Fujita S, Sokai A, et al. Effect of endoscopic sinus surgery for chronic rhinosinusitis on the state of coexisting asthma. Allergol Int. 2020;69(2):279–280. doi:10.1016/j.alit.2019.12.001
   PubMed Web of Science ®Google Scholar
• Akaba T, Kondo M, Muramatsu S, et al. Clinical characteristics and treatment outcomes of severe asthma patients with a history of multiple biologic drugs use. Asian Pac J Allergy Immunol. 2021. doi:10.12932/ap-170221-1070
   PubMed Web of Science ®Google Scholar
• Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68(4):403–412. doi:10.1016/j.alit.2019.07.002
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Wechsler ME, FitzGerald JM, et al. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma. Eur Respir J. 2018;52:4. doi:10.1183/13993003.00936-2018
   Web of Science ®Google Scholar
• Scioscia G, Carpagnano GE, Quarato CMI, et al. Effectiveness of benralizumab in improving the quality of life of severe eosinophilic asthmatic patients: our real-life experience. Front Pharmacol. 2021;12:631660. doi:10.3389/fphar.2021.631660
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Fouka E, Papakosta D, Papiris S, Loukides S. Switching between biologics in severe asthma patients. When the first choice is not proven to be the best. Clin Exp Allergy. 2021;51(2):221–227. doi:10.1111/cea.13809
   PubMed Web of Science ®Google Scholar
• Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676–81.e1. doi:10.1016/j.jaci.2014.08.020
   PubMed Web of Science ®Google Scholar
• Hayashi H, Fukutomi Y, Mitsui C, et al. Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease. A randomized controlled trial. Am J Respir Crit Care Med. 2020;201(12):1488–1498. doi:10.1164/rccm.201906-1215OC
   PubMed Web of Science ®Google Scholar